Determining which draining method is best for Plural effusion - Wesley Research Institute
Wesley Research Institute
Donate
Now

This one year research project aims to compare two commonly used methods of draining the effusion to determine which one is best.

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Pleural Effusion

Study location

Wesley Research Institute

Study type

Investigator Initiated
find out if you’re eligible

Lead investigator

  • Dr Luke Garske

Clinical trial coordinators

  • Chris Henderson
  • Linda Pearce

Technical title

AMPLE-3: A Randomised Study Comparing Combined Indwelling Pleural Catheter (IPC) and Talc Pleurodesis with Video-Assisted Thoracoscopic Surgery (VATS) for the Management of Patients with Malignant Pleural Effusion

About this research project

The lung is covered by a thin lining which produces a very small amount of fluid to lubricate the lungs during breathing. Cancers can spread to this lining causing a build-up of fluid. This is called a malignant pleural effusion. The increased fluid can compress the lungs causing breathlessness. Draining the fluid can ease symptoms but it usually rapidly re-accumulates and needs further drainages.

This one year research project aims to compare two commonly used methods of draining the effusion to determine which one is best. One method involves a surgical procedure (VATS) and the other involves insertion of a long-term flexible chest tube (IPC). IPC and surgical pleurodesis are known to be safe procedures and are both commonly used; however, no one knows if one is better than the other at preventing the fluid from returning and further procedures being required.

 

Latest News

Jillian’s Story

This was my first experience at being involved in any sort of research. If I get the opportunity again, I would definitely put my hand up after the wonderful experience I had with your team. Thank you so much to Emma and all your team for making me feel so welcome.    Jillian Meet Jillian, retired […]

Breaking Ground in Paediatric Rare Disease Research

Wesley Research Institute is home to a groundbreaking trial using triheptanoin, a dietary fat, to treat Ataxia-Telangiectasia (A-T), a rare degenerative neurological disorder. This trial has shown promising results, with observed improvements in neurology scales and cellular biomarkers indicating the treatment’s effectiveness.

World-First ‘Back to the Future’ Research Set To Boost Pandemic Protection  

A world-first research project by two Queensland professors is set to offer a blueprint for developing more effective vaccines and therapies specifically tailored to safeguard the health of children and young adults in times of global health crises.  Spearheaded by Professor John Fraser, Dr Arutha Kulasinghe and Associate Professor Kirsty Short, this pioneering study, funded […]
1 2 3 12
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram